79
Views
2
CrossRef citations to date
0
Altmetric
Abstracts

Chiral memory and self-replication study of porphyrin and bilirubin aggregates formed on polypeptide matrices

, &
Pages 643-650 | Received 03 Jul 2007, Accepted 23 Aug 2007, Published online: 01 Oct 2008
 

Abstract

Porphyrin heteroaggregates composed of meso-tetrakis(N-methylpyridinium-4-yl)porphinatocopper(II) and meso-tetrakis(4-sulfonatophenyl)porphyrin formed in the presence of a polyglutamic matrix possess chiral memory and an ability to self-replicate their supramolecular structures. By means of electronic circular dichroism spectroscopy, it has been shown that the self-replication process is not influenced by changes in pH or ionic strength. The average molecular weight of the polyglutamic matrix used for porphyrin aggregate preparation plays a crucial role with regard to the form of the resulting CD spectrum. In the second part of our study, a complex composed of polylysine and bilirubin as a model system for a structured homoaggregate formed on the chiral matrix has been tested for chiral memory phenomena. The results indicate that the bilirubin homoaggregate shows chiral memory.

Acknowledgements

This work was supported by research grants from the Ministry of Education, Youth and Sports of the Czech Republic (MSM 6046137307, OC135) and from the Grant Agency of the Academy of Sciences of the Czech Republic (IAA 400550702).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.